Minor hallucinations reflect early gray matter loss and predict subjective cognitive decline in Parkinson's disease.
Helena Bejr-KasemF SampedroJuan Marín-LahozS Martínez-HortaJ PagonabarragaJ KulisevskyPublished in: European journal of neurology (2020)
Minor hallucinations seem to be an early clinical marker of increased neurodegeneration and are associated with mid-term subjective cognitive decline. Longer follow-up analyses would be needed to further define if these findings could reflect a higher risk of future cognitive deterioration.